CRIS Current Research Information System

ZACCHERINI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.061
EU - Europa 2.260
AS - Asia 1.555
AF - Africa 153
SA - Sud America 12
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.042
IT - Italia 646
VN - Vietnam 568
GB - Regno Unito 401
CN - Cina 390
SG - Singapore 378
SE - Svezia 370
DE - Germania 225
IN - India 115
IE - Irlanda 94
RU - Federazione Russa 94
TG - Togo 76
CH - Svizzera 71
FR - Francia 71
BG - Bulgaria 68
FI - Finlandia 43
JO - Giordania 39
CI - Costa d'Avorio 37
UA - Ucraina 34
NL - Olanda 27
ZA - Sudafrica 26
AT - Austria 23
EE - Estonia 22
ES - Italia 20
CA - Canada 16
HK - Hong Kong 16
BE - Belgio 14
ID - Indonesia 14
IR - Iran 13
HR - Croazia 11
NG - Nigeria 10
CL - Cile 7
LT - Lituania 6
CZ - Repubblica Ceca 5
PL - Polonia 5
JP - Giappone 4
RO - Romania 4
AU - Australia 3
NZ - Nuova Zelanda 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
MX - Messico 2
PH - Filippine 2
PK - Pakistan 2
VA - Santa Sede (Città del Vaticano) 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CU - Cuba 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
MY - Malesia 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 7.048
Salva come PNG Salva come JPEG
Città #
Southend 357
Dong Ket 340
Fairfield 336
Singapore 329
Chandler 324
Ashburn 218
Santa Clara 201
Woodbridge 158
Houston 145
Bologna 144
Wilmington 132
Cambridge 121
Seattle 121
Princeton 112
Ann Arbor 105
Dublin 92
Boardman 83
Lomé 76
Sofia 67
Bern 65
Milan 46
Amman 39
New York 39
Abidjan 37
Helsinki 35
Westminster 33
Berlin 32
Nanjing 29
Beijing 28
San Diego 27
Shenyang 27
Turin 24
Jinan 23
Padova 23
Florence 21
Des Moines 17
Guangzhou 17
Redmond 17
Zhengzhou 17
Hebei 16
Rome 16
Saint Petersburg 15
Hong Kong 14
Nuremberg 14
Casalecchio di Reno 13
Changsha 13
Vienna 13
Bremen 12
Jakarta 12
Shanghai 12
Los Angeles 11
Medford 11
Modena 11
Paris 11
Abeokuta 10
Amsterdam 10
Brussels 10
Faenza 10
Ningbo 10
Verona 10
Fremont 9
Haikou 9
Hyderabad 9
Olalla 9
Parma 9
Toronto 9
Barcelona 8
Hangzhou 8
Lappeenranta 8
Brescia 7
Columbus 7
Frankfurt am Main 7
Jacksonville 7
Phoenix 7
Shenzhen 7
Falkenstein 6
London 6
Norwalk 6
Reggio Emilia 6
Tianjin 6
Xi'an 6
Fuzhou 5
Gatteo 5
Jiaxing 5
Lanzhou 5
Naples 5
Redwood City 5
Washington 5
Andover 4
Antwerp 4
Ardabil 4
Chengdu 4
Dearborn 4
Falls Church 4
Fusignano 4
Gava 4
Genoa 4
Madrid 4
Mülheim 4
Nanchang 4
Totale 4.550
Salva come PNG Salva come JPEG
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 335
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 306
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 234
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 183
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment 169
A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge 168
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 159
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 157
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 149
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 145
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 140
null 138
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 138
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 137
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 136
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 136
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 131
A Case of Immune-Mediated Liver Injury Induced by Olaparib 129
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 128
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 127
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 125
Role of human albumin in the management of complications of liver cirrhosis. 123
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 120
Development and validation of a prognostic score to predict mortality in patients with acute on chronic liver failure. 115
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 115
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 115
QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? 110
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 109
Human albumin in the management of complications of liver cirrhosis. 107
Assessing the role of amino acids in systemic inflammation and organ failure in patients with {ACLF} 105
Disorders of albumin metabolism in liver diseases. 104
Hyposplenism as a cause of pneumococcal meningoencephalitis in an adult patient with coeliac disease 104
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial 104
Human albumin in the management of complications of cirrhosis. 98
A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic 96
Approach and management of dysnatremias in cirrhosis 94
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis. 92
null 88
Pro: The Role of Albumin in Pre–Liver Transplant Management 87
Albumin: Indications in chronic liver disease 84
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 82
Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference 81
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis 81
Management of cirrhotic patients with ascites. 78
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology 78
Albumin administration in internal medicine: A journey between effectiveness and futility 78
Management of ascites in patients with cirrhosis: An update 76
Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature 75
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects 74
Hemodynamic and Systemic Effects of Albumin in Patients with Advanced Liver Disease 72
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 70
Real-word experience of long-term albumin treatment in a large cohort of patients with cirrhosis and ascites (Real-Answer study) 68
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium 68
null 59
Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database 54
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis 53
The Use of Rifaximin in Patients With Cirrhosis 51
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 44
The Role of Transjugular Intrahepatic Portosystemic Shunt for the Management of Ascites in Patients with Decompensated Cirrhosis 42
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 42
Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study 41
Prevention of cirrhosis complications: Looking for potential disease modifying agents 41
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 39
The role and indications of albumin in advanced liver disease 38
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 33
Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 32
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 31
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 30
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis 29
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis 28
Albumin in hospitalized patients with complications of cirrhosis: Not a suit for all seasons 25
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 25
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure. 24
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 21
Real-world experience with long-term albumin in patients with cirrhosis and ascites 19
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 18
Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial 17
Managing Multiorgan Failure in Acute on Chronic Liver Failure 16
Predictors of clinical trajectories in patients admitted for acutely decompensated cirrhosis: An external validation of the PREDICT study 16
Predictors of clinical courses in patients wih acutely decompensated cirrhosis. An external validation of the PREDICT study 14
Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009)) 12
null 3
null 3
null 1
Totale 7.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.674
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020519 0 0 0 0 0 0 0 154 196 95 47 27
2020/20211.115 126 45 28 28 11 28 37 78 104 37 55 538
2021/20221.390 157 27 63 84 118 80 35 142 56 74 403 151
2022/20231.415 111 220 77 140 94 114 42 91 235 44 120 127
2023/2024679 32 72 53 80 38 132 31 45 19 36 95 46
2024/20251.489 107 358 207 203 316 138 122 38 0 0 0 0
Totale 7.322